(Q43832490)

27 November 2017

Inhibition of epidermal growth factor receptor tyrosine kinase by chalcone derivatives (English)

1 reference

27 November 2017

E B Yang

1

1 reference

27 November 2017

Y J Guo

2

1 reference

27 November 2017

K Zhang

3

1 reference

27 November 2017

Y Z Chen

4

1 reference

27 November 2017

P Mack

5

1 reference

27 November 2017

1 December 2001

1 reference

Biochimica et Biophysica Acta

27 November 2017

1 reference

27 November 2017

1550

1 reference

27 November 2017

2

1 reference

27 November 2017

144-152

1 reference

Signal transduction by receptors with tyrosine kinase activity

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Protein kinases in human breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

EGF receptor expression, regulation, and function in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Specific inhibition of epidermal growth factor receptor tyrosine kinase by 4-anilinoquinazolines

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Specific, irreversible inactivation of the epidermal growth factor receptor and erbB2, by a new class of tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Tyrosine kinase inhibitors. 14. Structure-activity relationships for methylamino-substituted derivatives of 4-[(3-bromophenyl)amino]-6-(methylamino)-pyrido[3,4-d]pyrimidine (PD 158780), a potent and specific inhibitor of the tyrosine kinase activity

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Tyrosine kinase inhibitors. 15. 4-(Phenylamino)quinazoline and 4-(phenylamino)pyrido[d]pyrimidine acrylamides as irreversible inhibitors of the ATP binding site of the epidermal growth factor receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

4-(Phenylamino)pyrrolopyrimidines: potent and selective, ATP site directed inhibitors of the EGF-receptor protein tyrosine kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Genistein, a tyrosine kinase inhibitor, reduces EGF-induced EGF receptor internalization and degradation in human hepatoma HepG2 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Butein, a specific protein tyrosine kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Glutathione conjugation of chlorambucil: measurement and modulation by plant polyphenols

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Inhibition of the efflux of glutathione S-conjugates by plant polyphenols

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Inhibition of glutathione reductase by plant polyphenols

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Detection of EGF-induced EGF receptor degradation and tyrosine phosphorylation in intact cells

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Crystal structure of the activated insulin receptor tyrosine kinase in complex with peptide substrate and ATP analog

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Gapped BLAST and PSI-BLAST: a new generation of protein database search programs

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

The protein kinase family: conserved features and deduced phylogeny of the catalytic domains

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Restart procedures for the conjugate gradient method

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

A geometric approach to macromolecule-ligand interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Molecular docking using shape descriptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Automated docking with grid-based energy evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Conic: a fast renderer for space-filling molecules with shadows

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

The epidermal growth factor receptor and its inhibition in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

Daphnetin, one of coumarin derivatives, is a protein kinase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0167-4838%2801%2900276-X

7 January 2021

10.1016/S0167-4838(01)00276-X

Identifiers

DOI

1 reference

27 November 2017

1 reference